BACKGROUND: Osteoblastic metastases are commonly induced by prostate cancer. A canine prostate carcinoma xenograft (Ace-1) was developed and used to evaluate neoplastic prostate cell growth, metastasis, and effects on bone formation in nude mice. METHODS: Characteristics of the Ace-1 cells were evaluated with histopathology, radiography, and bioluminescent imaging (BLI). Immunohistochemistry and quantitative RT-PCR were used to evaluate the expression of factors important in the development of osteoblastic metastases. RESULTS: The Ace-1 cells were invasive and induced bone formation and destruction. Radiographs demonstrated a mixed osteoblastic/osteolytic reaction. Lung and lymph node metastases occurred in 30% of mice. The tumor cells expressed parathyroid hormone-related protein (PTHrP-141 isoform), cathepsin K, keratins 8/18, and vimentin, but not keratins 5/14, and were androgen receptor negative. Intracardiac (IC) injections resulted in metastases in vertebrae and long bones. CONCLUSIONS: The Ace-1 xenograft is a useful model for investigating the pathogenesis of prostate cancer invasion and mixed osteoblastic/osteolytic bone metastases. (c) 2006 Wiley-Liss, Inc.
BACKGROUND:Osteoblastic metastases are commonly induced by prostate cancer. A canineprostate carcinoma xenograft (Ace-1) was developed and used to evaluate neoplastic prostate cell growth, metastasis, and effects on bone formation in nude mice. METHODS: Characteristics of the Ace-1 cells were evaluated with histopathology, radiography, and bioluminescent imaging (BLI). Immunohistochemistry and quantitative RT-PCR were used to evaluate the expression of factors important in the development of osteoblastic metastases. RESULTS: The Ace-1 cells were invasive and induced bone formation and destruction. Radiographs demonstrated a mixed osteoblastic/osteolytic reaction. Lung and lymph node metastases occurred in 30% of mice. The tumor cells expressed parathyroid hormone-related protein (PTHrP-141 isoform), cathepsin K, keratins 8/18, and vimentin, but not keratins 5/14, and were androgen receptor negative. Intracardiac (IC) injections resulted in metastases in vertebrae and long bones. CONCLUSIONS: The Ace-1 xenograft is a useful model for investigating the pathogenesis of prostate cancer invasion and mixed osteoblastic/osteolytic bone metastases. (c) 2006 Wiley-Liss, Inc.
Authors: Sandra M Axiak-Bechtel; Senthil R Kumar; Kristin K Dank; Nicole A Clarkson; Kim A Selting; Jeffrey N Bryan; Thomas J Rosol; Jahna Espinosa; Charles J Decedue Journal: Invest New Drugs Date: 2013-09-13 Impact factor: 3.850
Authors: Xin Li; Jinhui Liao; Serk In Park; Amy J Koh; William D Sadler; Kenneth J Pienta; Thomas J Rosol; Laurie K McCauley Journal: Bone Date: 2011-03-17 Impact factor: 4.398
Authors: Jessica K Simmons; Wessel P Dirksen; Blake E Hildreth; Carlee Dorr; Christina Williams; Rachael Thomas; Matthew Breen; Ramiro E Toribio; Thomas J Rosol Journal: Prostate Date: 2014-07-07 Impact factor: 4.104
Authors: Lisa Y Wu; Jacqueline M Johnson; Jessica K Simmons; Desiree E Mendes; Jonathan J Geruntho; Tiancheng Liu; Wessel P Dirksen; Thomas J Rosol; William C Davis; Clifford E Berkman Journal: Prostate Date: 2014-01-21 Impact factor: 4.104
Authors: Said M Elshafae; Wessel P Dirksen; Aylin Alasonyalilar-Demirer; Justin Breitbach; Shiyu Yuan; Noriko Kantake; Wachiraphan Supsavhad; Bardes B Hassan; Zayed Attia; Lucas B Alstadt; Thomas J Rosol Journal: Prostate Date: 2020-04-29 Impact factor: 4.104
Authors: Chaojie Wang; Motoyasu Saji; Steven E Justiniano; Adlina Mohd Yusof; Xiaoli Zhang; Lianbo Yu; Soledad Fernández; Paul Wakely; Krista La Perle; Hiroshi Nakanishi; Neal Pohlman; Matthew D Ringel Journal: JCI Insight Date: 2017-03-09
Authors: Jinlu Dai; Honglai Zhang; Andreas Karatsinides; Jill M Keller; Kenneth M Kozloff; Dana T Aftab; Frauke Schimmoller; Evan T Keller Journal: Clin Cancer Res Date: 2013-10-04 Impact factor: 12.531
Authors: Kenneth J Pienta; Cory Abate-Shen; David B Agus; Ricardo M Attar; Leland W K Chung; Norman M Greenberg; William C Hahn; John T Isaacs; Nora M Navone; Donna M Peehl; Jonathon W Simons; David B Solit; Howard R Soule; Terry A VanDyke; Michael J Weber; Lily Wu; Robert L Vessella Journal: Prostate Date: 2008-05-01 Impact factor: 4.104